Discovery of IHMT-337 as a potent irreversible EZH2 inhibitor targeting CDK4 transcription for malignanciesHusheng Mei, Qingsong Liu, Jing Yang et al.|Signal Transduction and Targeted Therapy|2023Cited by 46
Discovery of a highly selective VEGFR2 kinase inhibitor CHMFL-VEGFR2-002 as a novel anti-angiogenesis agentZongru Jiang, Qingsong Liu|Acta Pharmaceutica Sinica B|2019Cited by 35